Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix Leads Gainers in GWDN Index in August; Hits 52-Week High Today

NEW YORK (GenomeWeb News) – Shares of CombiMatrix rose nearly 28 percent during the month of August, propelled by second-quarter revenue growth of 55 percent. The firm’s shares have risen sharply since the release of those results and hit another 52-week high today of $16.38.
 
The Mukilteo, Wash.-based molecular diagnostics firm led all gainers in the GenomeWeb Daily News Index for the month of August. The only other stock to eclipse the 20-percent growth mark for the month was that of Bio-Rad Laboratories, which was up around 21 percent.
 
Bio-Rad’s shares also shot up after the firm reported strong second-quarter results at the beginning of the month. The firm said that its Q2 revenues had risen 33 percent and its profit jumped 69 percent.
 
The stocks of four companies in the Index — DeCode Genetics, Nanogen, Caliper Life Sciences, and Helicos BioSciences — dropped more than 20 percent in August. The biggest decliner was DeCode Genetics, which fell around 31 percent, reversing a positive trend in July.
 
DeCode Genetics was the top stock in the Index for the month of July, climbing 70.2 percent. It rose steadily throughout July after falling to below $1 per share in June. The stock also got a boost later in July after the firm was featured in a report on NBC Nightly News.
 
Overall, the Index gained 2.9 percent in August, beating out the Dow Jones Industrial Average (+1.5 percent), the Nasdaq (+1.8 percent), and the Nasdaq Biotech Index (-3.5 percent).
 
While GenomeWeb Daily News covers many more firms than the 35 that are in the Index, those that have been included have a significant portion of their business focused on molecular biology and cellular research tools and are publicly traded in the US.
 
 
GenomeWeb Daily News Index
Company
Ticker
Current Price
(Aug. 29, 2008)
Last
Price
(July 31, 2008)
% change
Accelrys
ACCL
5.13
5.59
-8.23
Accelr8
AXK
3.92
4.42
-11.31
Affymetrix
AFFX
8.58
7.88
8.88
Agilent
A
34.76
36.06
-3.61
Applied Biosystems
ABI
36.49
36.93
-1.19
Beckman
BEC
73.82
72.34
2.05
Becton Dickinson
BDX
87.38
84.91
2.91
Bio-Rad
BIO
107.60
89.10
20.76
Bruker
BRKR
15.44
13.82
11.72
Caliper
CALP
2.99
3.97
-24.69
Celera
CRA
14.00
13.65
2.56
Cepheid
CPHD
18.60
17.12
8.64
Clinical Data
CLDA
16.53
17.10
-3.33
CombiMatrix
CBMX
14.36
11.24
27.76
Compugen
CGEN
2.05
2.29
-10.48
DeCode Genetics
DCGN
1.11
1.60
-30.63
Genomic Health
GHDX
22.38
21.54
3.90
Gen-Probe
GPRO
59.75
53.32
12.06
Helicos BioSciences
HLCS
4.04
5.25
-23.05
Illumina
ILMN
86.13
93.24
-7.63
Invitrogen
IVGN
42.46
44.35
-4.26
Luminex
LMNX
25.49
22.00
15.86
MDS
MDZ
15.31
14.01
9.28
Millipore
MIL
75.01
70.35
6.62
Nanogen
NGEN
0.33
0.44
-25.00
Nanosphere
NSPH
9.55
9.89
-3.44
Orchid Cellmark
ORCH
3.27
3.19
2.51
PerkinElmer
PKI
28.41
29.10
-2.37
Qiagen
QGEN
21.16
18.79
12.61
Rosetta Genomics
ROSG
3.53
4.05
-12.84
Sequenom
SQNM
22.73
21.36
6.41
Sigma-Aldrich
SIAL
56.76
60.74
-6.55
Thermo
TMO
60.56
60.52
0.07
Vermillion
VRML
1.50
1.80
-16.67
Waters
WAT
68.25
67.94
0.46
GWDN Index Average29.98
29.14
2.89
The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.